<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00714779</url>
  </required_header>
  <id_info>
    <org_study_id>HK123</org_study_id>
    <nct_id>NCT00714779</nct_id>
  </id_info>
  <brief_title>Fluoxetine vs. Brief Psychotherapy for Major Depression</brief_title>
  <official_title>Fluoxetine vs. Brief Psychotherapy in the Treatment of Major Depression - a Randomized Comparative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Turku</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>KELA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Finnish State Grant</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Turku</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study we compare two treatments for major depression - fluoxetine and brief
      psychodynamic psychotherapy. In addition to more traditional outcome measures, we also
      measure the densities of 5HT-1A and D-2 receptors before and after the treatment. The main
      hypothesis is that brief psychotherapy is as effective as fluoxetine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a randomized comparison of two treatments for major depression - fluoxetine and
      brief psychodynamic psychotherapy. The patients are recruited from occupational health
      services and suffer from mild to moderate major depressive disorder. The treatments last for
      16 weeks. The main outcome measures include HAM-D, BDI, SOFAS, Rand-36. In addition to more
      traditional outcome measures, we also measure the densities of 5HT-1A and D-2 receptors
      before and after the treatment using Positron Emission Tomography (PET) . The main hypothesis
      is that brief psychotherapy is as effective as fluoxetine, but differences between the
      treatments are seen in PET scanning.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2000</start_date>
  <completion_date type="Actual">December 2004</completion_date>
  <primary_completion_date type="Actual">December 2004</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HAM-D</measure>
    <time_frame>0, 16 weeks, one year</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">85</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fluoxetine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Short-term psychodynamic psychotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluoxetine</intervention_name>
    <description>20-40 mg / day orally</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Short-term psychodynamic psychotherapy</intervention_name>
    <description>1 session / week for 16 weeks</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  MDD (mild to moderate)

          -  HDRS 15 or more, age 20-60 years

          -  No treatment for preceding 4 months

          -  No DSM-IV axis I or II comorbidity

          -  No severe somatic illness

          -  No contraindications for fluoxetine treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hasse Karlsson, MA, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University</affiliation>
  </overall_official>
  <verification_date>July 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 7, 2008</study_first_submitted>
  <study_first_submitted_qc>July 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2008</study_first_posted>
  <last_update_submitted>July 7, 2008</last_update_submitted>
  <last_update_submitted_qc>July 7, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 14, 2008</last_update_posted>
  <responsible_party>
    <name_title>Professor Hasse Karlsson</name_title>
    <organization>University of Turku</organization>
  </responsible_party>
  <keyword>Major depressive Disorder</keyword>
  <keyword>fluoxetine</keyword>
  <keyword>short-term psychodynamic psychotherapy</keyword>
  <keyword>PET</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluoxetine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

